Silencing of vanilloid receptor TRPV1 by RNAi reduces neuropathic and visceral pain in vivo

This publication has 29 references indexed in Scilit:

• RNA Interference as A Gene-Specific Approach for Molecular Medicine
  Current Medicinal Chemistry, 2005
• Monitor – New TRPV1-targeting agents for pain management
  Drug Discovery Today, 2005
• Structure and function of TRPV1
  Pflügers Archiv - European Journal of Physiology, 2005
• A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1
  Proceedings of the National Academy of Sciences, 2005
• Biochemical pharmacology of the vanilloid receptor TRPV1
  European Journal of Biochemistry, 2004
• Potential applications of siRNA for pain therapy
  Expert Opinion on Biological Therapy, 2004
• N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2 H)-carbox-amide (BCTC), a Novel, Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties: II. In Vivo Characterization in Rat Models of Inflammatory and Neuropathic Pain
  The Journal of Pharmacology and Experimental Therapeutics, 2003
• Can we conquer pain?
  Nature Neuroscience, 2002
• The Cloned Capsaicin Receptor Integrates Multiple Pain-Producing Stimuli
  Neuron, 1998
• The capsaicin receptor: a heat-activated ion channel in the pain pathway
  Nature, 1997